This policy brief outlines evidence demonstrating the different health outcomes women, men, girls, boys, and gender-diverse populations experience related to drug-resistant infections (DRIs) from prevention to treatment. It presents policy recommendations that countries can adapt to their local context. The policy brief directly builds on findings from the WHO Guidance document on Addressing Gender Inequalities in National Action Plans on Antimicrobial Resistance (4).
resources